CA3213764A1 - Topical wipe containing nifedipine and lidocaine - Google Patents
Topical wipe containing nifedipine and lidocaine Download PDFInfo
- Publication number
- CA3213764A1 CA3213764A1 CA3213764A CA3213764A CA3213764A1 CA 3213764 A1 CA3213764 A1 CA 3213764A1 CA 3213764 A CA3213764 A CA 3213764A CA 3213764 A CA3213764 A CA 3213764A CA 3213764 A1 CA3213764 A1 CA 3213764A1
- Authority
- CA
- Canada
- Prior art keywords
- wipe
- lidocaine
- concentration
- topical
- nifedipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169768P | 2021-04-01 | 2021-04-01 | |
| US63/169,768 | 2021-04-01 | ||
| PCT/US2022/023130 WO2022212892A1 (en) | 2021-04-01 | 2022-04-01 | Topical wipe containing nifedipine and lidocaine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3213764A1 true CA3213764A1 (en) | 2022-10-06 |
Family
ID=83456873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3213764A Pending CA3213764A1 (en) | 2021-04-01 | 2022-04-01 | Topical wipe containing nifedipine and lidocaine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240156756A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4312984A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024512791A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117377461A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022252406A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3213764A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023011498A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022212892A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04124128A (ja) * | 1990-09-13 | 1992-04-24 | Lion Corp | 肛門部疾患治療用貼付剤 |
| JP3012732U (ja) * | 1994-12-20 | 1995-06-27 | 茂郎 槇島 | 痔治療の薬剤保持部材 |
| IT1297886B1 (it) * | 1997-02-28 | 1999-12-20 | Carmine Antropoli | Nifedipina per uso topico |
| JP2001170159A (ja) * | 1999-12-19 | 2001-06-26 | Alcare Co Ltd | 緩衝能を有する接皮部材 |
| US20040167479A1 (en) * | 2003-02-20 | 2004-08-26 | The Procter & Gamble Company | Hemorrhoid treatment pad |
| US8377459B2 (en) * | 2003-07-09 | 2013-02-19 | The Procter & Gamble Company | Composition for wet wipes that enhances the efficacy of cleansing while being gentle to the skin |
| WO2014140925A2 (en) * | 2013-03-10 | 2014-09-18 | Peritech Pharma Ltd. | Topical compositions and methods of treatment of topical disorders |
| PT3220924T (pt) * | 2014-11-17 | 2022-01-12 | Rev Pharma Corp | Medicamento tópico para lesões da pele e mucosas associadas à epidermólise bolhosa |
| WO2016118040A1 (ru) * | 2015-01-21 | 2016-07-28 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Гель, содержащий нифедипин и лидокаина гидрохлорид, его применение и способ приготовления с использованием нанотехнологий |
| IT201800002413A1 (it) * | 2018-02-05 | 2019-08-05 | Carmine Antropoli | "composizione a base di nifedipina per uso nel trattamento delle ragadi anali e proctalgie" |
| BR102018008324A2 (pt) * | 2018-04-25 | 2019-11-05 | Laboratórios Ferring Ltda. | composição farmacêutica de uso tópico e processo de fabricação de composição farmacêutica de uso tópico |
| EA036752B1 (ru) * | 2019-02-25 | 2020-12-16 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" | Способ получения геля для ректального и наружного применения, включающего нифедипин и лидокаина гидрохлорид (варианты) |
-
2022
- 2022-04-01 WO PCT/US2022/023130 patent/WO2022212892A1/en not_active Ceased
- 2022-04-01 AU AU2022252406A patent/AU2022252406A1/en active Pending
- 2022-04-01 MX MX2023011498A patent/MX2023011498A/es unknown
- 2022-04-01 CN CN202280032680.8A patent/CN117377461A/zh active Pending
- 2022-04-01 EP EP22782323.4A patent/EP4312984A4/en active Pending
- 2022-04-01 CA CA3213764A patent/CA3213764A1/en active Pending
- 2022-04-01 JP JP2023561034A patent/JP2024512791A/ja active Pending
-
2023
- 2023-09-29 US US18/375,115 patent/US20240156756A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4312984A1 (en) | 2024-02-07 |
| MX2023011498A (es) | 2024-01-17 |
| US20240156756A1 (en) | 2024-05-16 |
| WO2022212892A1 (en) | 2022-10-06 |
| EP4312984A4 (en) | 2025-02-19 |
| CN117377461A (zh) | 2024-01-09 |
| AU2022252406A1 (en) | 2023-11-02 |
| WO2022212892A8 (en) | 2023-11-16 |
| JP2024512791A (ja) | 2024-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Khullar et al. | Emulgels: a surrogate approach for topically used hydrophobic drugs | |
| Panwar et al. | Emulgel: A review | |
| DE69822199T2 (de) | Arzneimittel und verfahren zur behandlung von aufmerksamkeitsstörungen und aufmerksamkeits-/hyperaktivitätsstörungen mit methylphenidat | |
| KR0143916B1 (ko) | 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법 | |
| US20080004329A1 (en) | Pharmaceutical compositions of ropinirole and methods of use thereof | |
| JP5927506B2 (ja) | １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法 | |
| US20140314815A1 (en) | Adhesive solid gel-forming formulations for dermal drug delivery | |
| US20120301517A1 (en) | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs | |
| US20070190124A1 (en) | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs | |
| US20070196452A1 (en) | Flux-enabling compositions and methods for dermal delivery of drugs | |
| JP2009519940A (ja) | 皮膚科学的状態を処置するための組成物および方法 | |
| Vanpariya et al. | Emulgel: A review | |
| AU2006284113A1 (en) | Pharmaceutical compositions with melting point depressant agents and method of making same | |
| JP2009519958A (ja) | 薬物の皮膚送達のための、フラックス化可能な組成物および方法 | |
| Parihar et al. | Emulgel: A topical preparation | |
| US20240050361A1 (en) | Topical product hands-free applicator drug delivery system and methods of making and using the same | |
| JP2009519956A (ja) | 薬物の皮膚送達のための組成物および方法 | |
| US20240156756A1 (en) | Topical wipe containing nifedipine and lidocaine | |
| Al-Jarsha et al. | A review on film forming drug delivery systems | |
| JP2014517061A (ja) | 薬物送達製剤 | |
| KR20200112918A (ko) | 유화 겔 조성물 | |
| US10328154B2 (en) | Topical compositions for improved delivery of active agents | |
| KR100192149B1 (ko) | 경피 투여형 제제 | |
| JP5619363B2 (ja) | 経皮吸収促進剤、並びにこれを含有する皮膚処理用製剤及び経皮吸収型製剤 | |
| Deshpande | In vitro diffusion studies for the assessment & optimization of the drug release from various dermatological formulations of hydroxyzine hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250502 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250502 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260223 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260327 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20260327 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260327 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260331 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260331 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20260331 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20260331 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260331 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260401 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260513 |